Impel Neuropharma to Present Pivotal, Phase 3 Data From
Data Will Evaluate Exploratory Efficacy Data from STOP-301 Study Evaluating INP104 Consistency of Response, Recurrence and Sustained Response Findings...
United States Rd American Headache Society Annual Scientific Meeting Data Will Evaluate Exploratory Efficacy Also Highlight Safety Tolerability Including Nausea Cardiovascular Safety
Source: globenewswire.com